Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Monotherapy in HeartMate 3 LVAS Patients
NCT03704220Unknown
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Aug 2018
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Open-label trial of aspirin in heart failure (HF), sponsored by Institute for Clinical and Experimental Medicine. Primary endpoint: Survival free rate of thromboembolic events at 90 days. Status: unknown.
02
Drugs
aspirin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03704220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03704220.